Literature DB >> 4984183

In vitro susceptibility of gram-negative bacilli to gentamicin.

J A Washington, R E Ritts, W J Martin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4984183

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  7 in total

1.  Providencia stuartii sepsis: a new challenge in the treatment of thermal injury.

Authors:  P W Curreri; H M Bruck; R B Lindberg; A D Mason; B A Pruitt
Journal:  Ann Surg       Date:  1973-02       Impact factor: 12.969

2.  Four-hour microbiological assay of gentamicin in serum.

Authors:  E Warren; R J Snyder; I I Washington JA
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

3.  Antibiotic synergy and antagonism against clinical isolates of Klebsiella species.

Authors:  R M D'Alessandri; D J McNeely; R M Kluge
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

4.  Emergence of gentamicin- and carbenicillin-resistant Pseudomonas aeruginosa in a hospital environment.

Authors:  W Gaman; C Cates; C F Snelling; B Lank; A R Ronald
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

5.  Susceptibility of Pseudomonas aeruginosa to gentamicin sulfate in vitro: lack of correlation between disc diffusion and broth dilution sensitivity data.

Authors:  W H Traub
Journal:  Appl Microbiol       Date:  1970-07

6.  Comparative in vitro activity of three aminoglycosidic antibiotics: BB-K8, kanamycin, and gentamicin.

Authors:  P K Yu; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1973-08       Impact factor: 5.191

7.  In vitro antibacterial activity of spectinomycin.

Authors:  I I Washington JA; P K Yu
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.